February 14, 2008
Bentley Pharmaceuticals announced its European subsidiaries have received approvals to market their omeprazole capsule products, through their licensees, in various territories in Europe. The approvals are for 10 mg. 20 mg. and 40 mg. dosage levels of omeprazole capsules under a Mutual Recognition Procedure (MRP) that grants simultaneous authorizations throughout the EU. Bentley's subsidiaries expect to supply omeprazole to their licensees in the major markets of Germany and Italy, as well as other EU countries. Omeprazole is marketed in the US under the trade name Prilosec by AstraZeneca and under the trade name Losec in Europe.